Abstract
Cell-based therapy is a promising and innovative new treatment for different degenerative and autoimmune diseases, and mesenchymal stromal cells (MSCs) from the bone marrow have demonstrated great therapeutic potential due to their immunosuppressive and regenerative capacities.
The establishment of methods for large-scale expansion of clinical-grade MSCs in vitro has paved the way for their therapeutic use in clinical trials. However, the clinical application of MSCs also requires cryopreservation and banking of the cell products. To preserve autologous or allogeneic MSCs for future clinical applications, a reliable and effective cryopreservation method is required.
Developing a successful cryopreservation protocol for clinical stem cell products, cryopreservation media, cryoprotectant agents (CPAs), the freezing container, the freezing temperature, and the cooling and warming rate are all aspects which should be considered.
A major challenge is the selection of a suitable cryoprotectant which is able to penetrate the cells and yet has low toxicity.
This chapter focuses on recent technological developments relevant for the cryopreservation of MSCs using the most commonly used cryopreservation medium containing DMSO and animal serum or human-derived products for research use and the animal protein-free cryopreservation media CryoStor (BioLife Solutions) for clinical use.
Key words
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bieback K, Kinzebach S, Karagianni M (2011) Translating research into clinical scale manufacturing of mesenchymal stromal cells. Stem Cells Int 2010:193519
Sensebe L, Bourin P, Tarte K (2011) Good manufacturing practices production of mesenchymal stem/stromal cells. Hum Gene Ther 22:19–26
Haack-Sorensen M, Friis T, Mathiasen AB et al (2013) Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up. Cell Transplant 22:521–528
Le BK, Frassoni F, Ball L et al (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371:1579–1586
Mathiasen AB, Jorgensen E, Qayyum AA et al (2012) Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived mesenchymal stromal cells in chronic ischemic heart failure (MSC-HF trial). Am Heart J 164:285–291
Ra JC, Kang SK, Shin IS et al (2011) Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med 9:181
Thirumala S, Goebel WS, Woods EJ (2013) Manufacturing and banking of mesenchymal stem cells. Expert Opin Biol Ther 13:673–691
Pegg DE (2015) Principles of cryopreservation. Methods Mol Biol 1257:3–19
Balci D, Can A (2013) The assessment of cryopreservation conditions for human umbilical cord stroma-derived mesenchymal stem cells towards a potential use for stem cell banking. Curr Stem Cell Res Ther 8:60–72
Janz FL, Debes AA, Cavaglieri RC et al (2012) Evaluation of distinct freezing methods and cryoprotectants for human amniotic fluid stem cells cryopreservation. J Biomed Biotechnol 2012:649353
Thirumala S, Goebel WS, Woods EJ (2009) Clinical grade adult stem cell banking. Organogenesis 5:143–154
Li Y, Lu RH, Luo GF, Pang WJ et al (2006) Effects of different cryoprotectants on the viability and biological characteristics of porcine preadipocyte. Cryobiology 53:240–247
Liu Y, Xu X, Ma X et al (2010) Cryopreservation of human bone marrow-derived mesenchymal stem cells with reduced dimethylsulfoxide and well-defined freezing solutions. Biotechnol Prog 26:1635–1643
Rowley SD, Feng Z, Chen L et al (2003) A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch. Bone Marrow Transplant 31:1043–1051
Thirumala S, Gimble JM, Devireddy RV (2010) Evaluation of methylcellulose and dimethyl sulfoxide as the cryoprotectants in a serum-free freezing media for cryopreservation of adipose-derived adult stem cells. Stem Cells Dev 19:513–522
Freimark D, Sehl C, Weber C et al (2011) Systematic parameter optimization of a Me(2)SO- and serum-free cryopreservation protocol for human mesenchymal stem cells. Cryobiology 63:67–75
Ginis I, Grinblat B, Shirvan MH (2012) Evaluation of bone marrow-derived mesenchymal stem cells after cryopreservation and hypothermic storage in clinically safe medium. Tissue Eng Part C Methods 18:453–463
Woods EJ, Thirumala S (2011) Packaging considerations for biopreservation. Transfus Med Hemother 38:149–156
Acker JP, Croteau IM (2004) Pre- and post-thaw assessment of intracellular ice formation. J Microsc 215(Pt 2):131–138
Heng BC (2009) Effect of Rho-associated kinase (ROCK) inhibitor Y-27632 on the post-thaw viability of cryopreserved human bone marrow-derived mesenchymal stem cells. Tissue Cell 41(5):376–380
Haack-Sorensen M, Friis T, Bindslev L et al (2008) Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy. Scand J Clin Lab Invest 68:192–203
Bieback K, Hecker A, Kocaomer A et al (2009) Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27:2331–2341
Castiglia S, Mareschi K, Labanca L et al (2014) Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in good manufacturing practice conditions. Cytotherapy 16:750–763
Perez-Ilzarbe M, Diez-Campelo M, Aranda P et al (2009) Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion 49:1901–1910
Hubel A (2001) Cryopreservation of HPCs for clinical use. Transfusion 41:579–580
Mamidi MK, Singh G, Husin JM et al (2012) Impact of passing mesenchymal stem cells through smaller bore size needles for subsequent use in patients for clinical or cosmetic indications. J Transl Med 10:229
Carvalho KA, Cury CC, Oliveira L et al (2008) Evaluation of bone marrow mesenchymal stem cell standard cryopreservation procedure efficiency. Transplant Proc 40:839–841
Cox MA, Kastrup J, Hrubisko M (2012) Historical perspectives and the future of adverse reactions associated with haemopoietic stem cells cryopreserved with dimethyl sulfoxide. Cell Tissue Bank 13:203–215
Hirata AA (1968) Cytolytic antibody assay by tryptic digestion of injured cells and electronic counting. J Immunol 91:625–632
Acknowledgments
The Aase and Ejnar Danielsens Foundation and the Research Foundation at Rigshospitalet supported the development of this protocol.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Haack-Sørensen, M., Ekblond, A., Kastrup, J. (2016). Cryopreservation and Revival of Human Mesenchymal Stromal Cells. In: Gnecchi, M. (eds) Mesenchymal Stem Cells. Methods in Molecular Biology, vol 1416. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3584-0_21
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3584-0_21
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3582-6
Online ISBN: 978-1-4939-3584-0
eBook Packages: Springer Protocols